Press Releases

CollabRx Announces Receipt of NASDAQ Notice of Non-Compliance with Rule 5550(b)(1)

San Francisco, CA – December 3, 2014 – CollabRx, Inc. (NASDAQ: CLRX) (herein “CLRX” or “the Company”), announced today that it received a letter from the NASDAQ OMX GROUP (“Nasdaq”) stating that the Company is in non-compliance with the Nasdaq Capital Market’s Listing Rule 5550(b)(1).  That rule requires the Company to maintain a minimum stockholder’s [...]

CollabRx Announces Receipt of NASDAQ Notice of Bid Price Deficiency

San Francisco, CA – November 24, 2014 – CollabRx, Inc. (NASDAQ: CLRX) (herein “CLRX” or “the Company”), announced today that it received a letter from the NASDAQ OMX GROUP (“Nasdaq”) stating that the bid price of the Company’s common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share [...]